The impact of COVID–19 has been broad reaching and unprecedented. It has forced us to reassess how we work, how we collaborate, how we engage with our employees, our customers and our professional network. The situation requires adaptability and rapid pivoting in...
We are delighted that our article ‘Stated preferences for relapsed or refractory mantle cell lymphoma treatments in Sweden and Germany’ has been published by Future Medicine. The article is based on work that Adelphi Research conducted with Janssen where we aimed to...
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
We’d like to set analytic software i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy.